Sep 16,2021

Analysis of Healthy Coping Feedback Messages from Diabetes Mobile Apps: Validation Against an Evidence-Based Framework

In this study, we focused on Healthy Coping, a key principle of ADCES7 Self-Care Behaviors® (ADCES7®) that enables people with diabetes to achieve health goals for self-care. We aimed to validate Healthy Coping-related feedback messages from diabetes mobile apps against the framework based on behavioral change theories.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Sep 16,2021

Diabeloop joins the AACE Corporate Advisory Program, Appoints US Scientific Advisors

Diabetes medtech company Diabeloop, which earlier this year commercially launched its Automated Insulin Delivery (AID) system in Europe, is moving forward in the US. It announced today that it joined the AACE Corporate Advisory Partnership and created its US Scientific Advisory Board.

View Analyst & Ambassador Comments
Go to original news
Sep 17,2021

DarioHealth Chief Medical Officer Dr. Omar Manejwala to Speak at American Health Insurance Plans National Conference on Medicare, Medicaid and Dual Eligibles

DarioHealth Corp., a pioneer in the global digital therapeutics market, today announced that the company's Chief Medical Officer, Dr. Omar Manejwala, will present at the annual American Health Insurance Plans National Conference on Medicare, Medicaid and Dual Eligibles being held virtually on September 22nd, 2021 at 12:45 p.m. EST.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Sep 20,2021

9am Health launches with $3.7M to tackle virtual diabetes care

San Diego-based company announced a $3.7 million seed round from Founders Fund, Define Ventures, Speedinvest and iSeed Ventures to target the 1 in 3 people living with diabetes in the United States, Westermann told TechCrunch.

FUNDING SEED ROUND

#telehealth

View Analyst & Ambassador Comments
Go to original news
Sep 21,2021

Nemaura Medical to Present at the Benzinga Healthcare Small Cap Conference

Nemaura Medical, Inc., a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces today that Chief Executive Officer Faz Chowdhury, Ph.D. will present at the Benzinga Healthcare Small Cap Conference, which is being held virtually from September 29 – 30, 2021.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Sep 22,2021

Prenome could help pregnant women better predict and manage gestational diabetes

Prenome, going through TechCrunch Disrupt Startup Battlefield this week, is launching a saliva-based genetic test, paired with a behavioral app, to help women navigate gestational diabetes, a common condition that comes up while pregnant.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Sep 22,2021

Welldoc Receives Ninth 510(k) for Award-Winning Diabetes Platform, BlueStar®

Welldoc, a digital health leader revolutionizing chronic care, today announced the receipt of its ninth 510(k) clearance from the Food and Drug Administration (FDA) for its award-winning diabetes platform, BlueStar®. The new clearance expands insulin dosing support to most types of insulin, including Bolus and Premixed Insulin titration for type 2 diabetes.

REGULATORY FDA

#dtx

View Analyst & Ambassador Comments
Go to original news
Sep 23,2021

Exploring Decentralized Glucose and Behaviometric Monitoring of Persons with Type 2 Diabetes in the Setting of a Clinical Trial

Clinical trials often suffer from recruitment barriers and poor adherence, which increases costs and affects trial outcomes. Patients with T2DM were recruited through a pharmacy and online recruitment using advert on Facebook, to 3 weeks monitoring of glucose and behaviometric parameters. Subjects recruited online could either complete an informed consent conversation in the pharmacy or through live video call managed by the study app. Objective: To investigate the feasibility of Decentralized Clinical Trial (DCT) design elements to recruit, enroll, and engage patients with type 2 diabetes mellitus (T2DM).

CLINICAL STUDY

#cgm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Sep 23,2021

ABBOTT HOSTS CONFERENCE CALL FOR THIRD-QUARTER EARNINGS

Abbott will announce its third-quarter 2021 financial results on Wednesday, Oct. 20, 2021, before the market opens. The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern), and will be accessible through Abbott's Investor Relations website at www.abbottinvestor.com. An archived edition of the call will be available later that day.

View Analyst & Ambassador Comments
Go to original news
Sep 23,2021

Patients’ Experience of New Technologies and Digitalization in Diabetes Care in Germany

Little is little known about how people with diabetes experience advancing digitization and new technologies in diabetes. This paper investigates: what are the attitudes of people with diabetes (or, in the case of children with diabetes, their parents) toward digitization and advancing technology in diabetology?, What significant advantages and disadvantages do they see, and how do they assess current developments of digitization in diabetology (eg, hybrid closed-loop systems, do-It-Yourself (DIY) closed-loop systems, data protection, and data donation)?

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES